Word: gardasil
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...increasingly common sexually transmitted disease and one that scientists say is linked to 70% of all cases of cervical cancer. Gardasil, the first vaccine to fight cancer, was approved by the Food and Drug Administration last June. The CDC says the vaccine has been tested, is safe and goes a long way toward preventing the deadly cancer which is estimated to have affected 9,710 women in 2006, killing...
...Gardasil, a new vaccine approved this year, prevents 70% of the cases of what kind of cancer? A Prostate...
...June the FDA approved a vaccine to protect against cervical cancer, the second most common cancer in women. The vaccine, called Gardasil, immunizes against four of the most prevalent strains of the human papillomavirus (HPV), the most common sexually transmitted infection and the cause of 70% of cervical-cancer cases. Because the vaccine is most effective when administered before girls become sexually active, a government committee recommended that it be given routinely to girls ages 11 and 12--which immediately triggered cries of alarm from pro-abstinence groups that feared doing so would encourage promiscuity. Some health advocates were also...
...keep students from getting it. The Harvard College Women’s Center (HCWC), the Seneca, and 13 other student organizations are leading the Harvard HPV Vaccine Awareness Campaign to inform women of the benefits of vaccination, and to gauge interest in urging UHS to make the vaccine, Gardasil, more affordable. “This is definitely a resource for women that will hopefully have a very large effect on women’s health,” said Katie E. Koopman ’08, chair of the Seneca’s Women’s Outreach Committee. Koopman...
...Gardasil is not a panacea for preventing cervical cancer: It isn’t absolutely effective, and women should continue to undergo regular cervical cancer screening. But the health benefits of the vaccine are already promising. We commend both the FDA and UHS for making the vaccine more readily accessible, and we commend the ACIP for its recommendations...